Your Renewal Percentage Is Not a Diagnosis
A self-funded health plan renewal can turn twelve months of decisions, claims, contracts, and employee behavior into one percentage. That number matters to the budget. It does not tell leadership what to do next.
A recent BRMS renewal article makes a useful point: employers should connect the financial result to the forces that created it before they accept a proposal, shift costs to employees, or change the plan. The source highlights claims, pharmacy activity, provider rates, utilization, stop-loss terms, vendor performance, and implementation time as parts of that review.
For a CEO or CFO, the practical lesson is simple. A 14% increase is an outcome. It is not a diagnosis.
Build a renewal variance bridge
Imagine a Midwest manufacturer receives a double-digit renewal. The first reaction may be to market the plan, raise deductibles, or increase employee contributions. Those may become valid options. But acting before the increase is explained can spread the pain across the workforce without addressing the cause.
Ask the team to build a renewal variance bridge. Start with last year's expected cost, then show what moved the result. Separate the change into understandable categories:
- Large claims that are closed, continuing, or likely to recur.
- Medical utilization changes by service category and site of care.
- Pharmacy trend, including specialty drugs, rebates, and contract terms.
- Network price changes and provider-contract effects.
- Stop-loss premium, deductible, exclusions, lasers, and contract basis.
- Administrative fees, point solutions, and other vendor costs.
- Workforce, enrollment, and contribution changes.
The categories do not need false precision. They do need enough evidence to show which pressures are temporary, which are structural, and which are still unknown.
Self-funding makes the explanation actionable
In a fully insured plan, an employer may receive limited visibility into the carrier's pricing. A self-funded employer has more opportunity to connect claims experience, contracts, and plan decisions. That opportunity only becomes control when the data is usable and the contracts allow leadership to act.
If the increase comes mainly from a few completed claims, a workforce-wide benefit reduction may be a poor match. If specialty pharmacy spending is accelerating, changing the medical deductible will not solve the pharmacy contract. If hospital prices are the main driver, the response may involve network analysis, navigation, direct contracting, or payment strategy. If the stop-loss renewal changed, leadership needs to understand the coverage terms as well as the premium.
The point is not to chase every solution. It is to match each proposed action to a documented cost driver.
Make every recommendation pass four tests
Before approving a renewal change, ask the advisor or vendor to put four answers in the decision file:
- Evidence: What specific plan data or contract term supports this recommendation?
- Economics: What is the expected gross savings, total cost, timing, and range of outcomes?
- Employee effect: Which employees will notice the change, and what will they experience?
- Execution: Who owns contracts, data feeds, plan documents, enrollment materials, member support, and measurement?
This is where many attractive ideas become operationally weak. A projected saving is not a result if the new vendor cannot receive clean eligibility data, employees cannot find care, or the company cannot explain the change before January 1.
What leadership should have before signing
A defensible renewal file should fit into one executive conversation. It should show:
- The renewal variance bridge and the assumptions behind it.
- The three largest continuing cost pressures.
- The options considered, including the effect of doing nothing.
- Contract changes, vendor responsibilities, and data rights.
- Employee disruption and the communication plan.
- A 90-day implementation calendar with named owners.
- The measures leadership will review after the plan goes live.
Superior Insurance Advisors helps employers organize this kind of review in plain English. Paul.Health gives leaders a direct place to start the conversation when the renewal number is clear but the cause is not.
The best decision question is not, “Can we get a lower renewal?” It is: Can our team explain which dollars are likely to repeat, which action addresses each one, and who is accountable after we sign?
If the answer is no, the renewal is still a price—not yet a strategy.
Book a plan review at Paul.Health and bring the renewal, stop-loss terms, vendor contracts, and latest medical and pharmacy reporting.
This article is for educational purposes and is not legal, tax, actuarial, or medical advice.